An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples